Clinical Trial Update: Investigating the Immune Response to 4CMenB in Infants [Phase 4]

View source ↗

Summary

Phase 4 trial updates the immune response to the 4CMenB vaccine in infants with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis

Drugs mentioned

• 4CMenB (bivalent group B meningococcal vaccine (4CMenB))

Snippet

Sponsor: University of Oxford | Conditions: Meningitis | Phase 4 | Status: COMPLETED